Kyle Yang

Kyle Yang, CFA, is a biotechnology equity research associate director at UBS, specializing in pharma and biotech. Previously, Kyle worked as a senior associate at Jefferies, focusing on SMID and Large Cap biotech equity research, and held an associate position at Oppenheimer & Co. Inc. in SMID Cap biotech equity research. Kyle's experience also includes serving as a senior investment analyst at SOSV in early-stage venture capital. Kyle earned a Bachelor's degree in Chemistry from ShanghaiTech University, a Master's degree in Biotechnology from Columbia University, and studied Molecular and Cellular Biology at the University of California, Berkeley.